2nd annual Pharmaceutical Microbiology

Organization: SMi Group

Venue: Marriott London Regents Park

Location: London, United Kingdom

Event Date/Time: Jan 30, 2013 End Date/Time: Jan 31, 2013
Report as Spam


 Microbiological contamination of products in lab manufacturing environments continues to be a major problem for all pharmaceutical and biotech companies. The potential impact of such contamination can be enormous, causing health & safety problems for staff and customers, but also costing companies millions in lost product revenue.

Don’t miss SMi’s 2nd annual Pharmaceutical Microbiology conference that aims to provide an expert and highly accredited speaker line up including 13 pharma speakers who will focus on the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry.

Reasons you should not miss this incredible event includes:


·         Discuss developments in tools, techniques and procedures used in identification and control of contaminants

·         Evaluate the handling of traditional drug and biologics & sterile product manufacturing

·         Hear about design, construction and validation of sterile facilities and equipment

·         Engage with those currently working on producing the rapid microbial methods


Key Speakers include:


·         Oliver Chancel, Microbiologist, Sanofi-Aventis

·         Kim Bowers, Senior Scientist, Pfizer

·         Praful Bhusari, Associate Scientist, MedImmune

·         John Duguid, Principle Analytical Scientist, Genzyme

·         Scott Smith, Microbiology Team Leader, Sanofi-Aventis

·         Anne Warford, Associate Director, MedImmune

·         Amy McDaniel, Director, QC Microbiology, Pfizer


128 King Henrys Road
United Kingdom


SMi Group